A Phase I/Ii Trial of Ibrutinib, Intratumoral CPG and Local Radiation in Patients With Low-Grade B-Cell Lymphoma: Interim Clinical and Correlative Results

Hematological Oncology - United Kingdom
doi 10.1002/hon.82_2629

Related search